Logo image of LSH

LAKESIDE HOLDING LTD (LSH) Stock Fundamental Analysis

NASDAQ:LSH - Nasdaq - US51216F1093 - Common Stock - Currency: USD

2.16  +0.03 (+1.41%)

Fundamental Rating

1

Taking everything into account, LSH scores 1 out of 10 in our fundamental rating. LSH was compared to 29 industry peers in the Marine Transportation industry. LSH may be in some trouble as it scores bad on both profitability and health. LSH has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

LSH had negative earnings in the past year.
In the past year LSH has reported a negative cash flow from operations.
LSH Yearly Net Income VS EBIT VS OCF VS FCFLSH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 500K

1.2 Ratios

LSH has a worse Return On Assets (-2.45%) than 85.71% of its industry peers.
With a Return On Equity value of -35.21%, LSH is not doing good in the industry: 92.86% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -2.45%
ROE -35.21%
ROIC N/A
ROA(3y)5.16%
ROA(5y)N/A
ROE(3y)25.08%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LSH Yearly ROA, ROE, ROICLSH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 50 100

1.3 Margins

LSH's Gross Margin of 20.29% is on the low side compared to the rest of the industry. LSH is outperformed by 85.71% of its industry peers.
LSH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.29%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LSH Yearly Profit, Operating, Gross MarginsLSH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 5 10 15 20

3

2. Health

2.1 Basic Checks

LSH does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LSH has been reduced compared to 1 year ago.
LSH has a better debt/assets ratio than last year.
LSH Yearly Shares OutstandingLSH Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2M 4M 6M
LSH Yearly Total Debt VS Total AssetsLSH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

An Altman-Z score of 2.64 indicates that LSH is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.64, LSH is doing good in the industry, outperforming 75.00% of the companies in the same industry.
A Debt/Equity ratio of 0.24 indicates that LSH is not too dependend on debt financing.
The Debt to Equity ratio of LSH (0.24) is better than 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z 2.64
ROIC/WACCN/A
WACC8.92%
LSH Yearly LT Debt VS Equity VS FCFLSH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 200K 400K 600K 800K

2.3 Liquidity

LSH has a Current Ratio of 0.60. This is a bad value and indicates that LSH is not financially healthy enough and could expect problems in meeting its short term obligations.
LSH has a Current ratio of 0.60. This is amonst the worse of the industry: LSH underperforms 85.71% of its industry peers.
A Quick Ratio of 0.60 indicates that LSH may have some problems paying its short term obligations.
LSH's Quick ratio of 0.60 is on the low side compared to the rest of the industry. LSH is outperformed by 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 0.6
Quick Ratio 0.6
LSH Yearly Current Assets VS Current LiabilitesLSH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 1M 2M 3M 4M 5M

1

3. Growth

3.1 Past

LSH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -128.62%.
Looking at the last year, LSH shows a very strong growth in Revenue. The Revenue has grown by 42.28%.
EPS 1Y (TTM)-128.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)42.28%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LSH Yearly Revenue VS EstimatesLSH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 5M 10M 15M
LSH Yearly EPS VS EstimatesLSH Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024

0

4. Valuation

4.1 Price/Earnings Ratio

LSH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LSH Price Earnings VS Forward Price EarningsLSH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LSH Per share dataLSH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

LSH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LAKESIDE HOLDING LTD

NASDAQ:LSH (1/27/2025, 12:00:04 PM)

2.16

+0.03 (+1.41%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryMarine Transportation
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.68%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner Change0%
Market Cap16.20M
AnalystsN/A
Price TargetN/A
Short Float %1.33%
Short Ratio0.42
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.88
P/FCF N/A
P/OCF N/A
P/B 25.32
P/tB 25.32
EV/EBITDA N/A
EPS(TTM)-0.17
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS2.44
BVpS0.09
TBVpS0.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.45%
ROE -35.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.29%
FCFM N/A
ROA(3y)5.16%
ROA(5y)N/A
ROE(3y)25.08%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.99
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.6
Quick Ratio 0.6
Altman-Z 2.64
F-Score3
WACC8.92%
ROIC/WACCN/A
Cap/Depr(3y)43.13%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.48%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-128.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)42.28%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-283.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-355.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-236.49%
OCF growth 3YN/A
OCF growth 5YN/A